Work

UK oncology approvals in 2022: global regulatory collaboration and new regulatory pathways deliver new anti-cancer therapies

Year: 2023

Type: article

Source: The Lancet Oncology

DOI: 10.1016/s1470-2045(23)00218-8

Authors: Mark P Lythgoe, Richard Sullivan, Sarah Blagden

Institutions: Imperial College London, King's College London, University of Oxford

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4386263379

FWCI: 1.016

Cites: 15

Cited by: 5

Related to: 10